全文获取类型
收费全文 | 22325篇 |
免费 | 4197篇 |
国内免费 | 148篇 |
专业分类
耳鼻咽喉 | 561篇 |
儿科学 | 605篇 |
妇产科学 | 525篇 |
基础医学 | 2021篇 |
口腔科学 | 406篇 |
临床医学 | 4522篇 |
内科学 | 4371篇 |
皮肤病学 | 526篇 |
神经病学 | 2023篇 |
特种医学 | 724篇 |
外国民族医学 | 1篇 |
外科学 | 3096篇 |
综合类 | 669篇 |
现状与发展 | 2篇 |
一般理论 | 9篇 |
预防医学 | 3171篇 |
眼科学 | 322篇 |
药学 | 1479篇 |
1篇 | |
中国医学 | 121篇 |
肿瘤学 | 1515篇 |
出版年
2023年 | 466篇 |
2022年 | 191篇 |
2021年 | 480篇 |
2020年 | 625篇 |
2019年 | 386篇 |
2018年 | 838篇 |
2017年 | 767篇 |
2016年 | 818篇 |
2015年 | 915篇 |
2014年 | 1008篇 |
2013年 | 1415篇 |
2012年 | 995篇 |
2011年 | 960篇 |
2010年 | 845篇 |
2009年 | 964篇 |
2008年 | 899篇 |
2007年 | 834篇 |
2006年 | 845篇 |
2005年 | 744篇 |
2004年 | 674篇 |
2003年 | 609篇 |
2002年 | 598篇 |
2001年 | 669篇 |
2000年 | 544篇 |
1999年 | 540篇 |
1998年 | 431篇 |
1997年 | 448篇 |
1996年 | 460篇 |
1995年 | 400篇 |
1994年 | 312篇 |
1993年 | 249篇 |
1992年 | 476篇 |
1991年 | 412篇 |
1990年 | 367篇 |
1989年 | 374篇 |
1988年 | 392篇 |
1987年 | 336篇 |
1986年 | 301篇 |
1985年 | 259篇 |
1984年 | 284篇 |
1983年 | 226篇 |
1982年 | 164篇 |
1981年 | 150篇 |
1980年 | 125篇 |
1979年 | 198篇 |
1978年 | 131篇 |
1976年 | 138篇 |
1975年 | 131篇 |
1974年 | 123篇 |
1972年 | 120篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
2.
Kara S. Tanaka MD Veronica R. Andaya BA Steven W. Thorpe MD Kenneth R. Gundle MD James B. Hayden MD Yee-Cheen Duong MD Raffi S. Avedian MD David G. Mohler MD Lee J. Morse MD Melissa N. Zimel MD Richard J. O'Donnell MD Andrew Fang MD Robert Lor Randall MD Tina H. Tran BS Christin New BA Rosanna L. Wustrack MD other members of Study Group FORCE 《Journal of surgical oncology》2023,127(1):148-158
3.
J. Savige L. Amos Frank Ierino H. G. Mack R. C. Andrew Symons P. Hughes 《Ophthalmic genetics》2016,37(4):369-376
Background: Dense deposit disease and atypical hemolytic uremic syndrome are often caused by Complement Factor H (CFH) mutations. This study describes the retinal abnormalities in dense deposit disease and, for the first time, atypical haemolytic uremic syndrome. It also reviews our understanding of drusen pathogenesis and their relevance for glomerular disease. Methods: Six individuals with dense deposit disease and one with atypical haemolytic uremic syndrome were studied from 2 to 40 years after presentation. Five had renal transplants. All four who had genetic testing had CFH mutations. Individuals underwent ophthalmological review and retinal photography, and in some cases, optical coherence tomography, and further tests of retinal function. Results: All subjects with dense deposit disease had impaired night vision and retinal drusen or whitish-yellow deposits. Retinal atrophy, pigmentation, and hemorrhage were common. In late disease, peripheral vision was restricted, central vision was distorted, and there were scotoma from sub-retinal choroidal neovascular membranes and atypical serous retinopathy. Drusen were present but less prominent in the young person with atypical uremic syndrome due to a heterozygous CFH mutation. Conclusions: Drusen are common in forms of C3 glomerulopathy caused by compound heterozygous or heterozygous CFH mutations. They are useful diagnostically but also impair vision. Drusen have an identical composition to glomerular deposits. They are also identical to the drusen of age-related macular degeneration, and may respond to the same treatments. Individuals with a C3 glomerulopathy should be assessed ophthalmologically at diagnosis, and monitored regularly for vision-threatening complications. 相似文献
4.
5.
目的 探讨在苯妥英钠(Phenytoin,PHT)促进大鼠牙周膜干细胞(Rat periodontal ligament stem cells,rPDLSCs)、大鼠骨髓间充质干细胞(Rat Bone Marrow Mesenchymal Stem Cells,rBMMSCs)黏附于牙骨质过程中,整合素α5β1(Integrin α5β1)起到的作用。方法 提取大鼠BMMSCs和PDLSCs,培养并纯化。通过细胞鉴定后,将获得的两种细胞各分为4组:40 mg/L PHT处理组、40 mg/L PHT+整合素α5抗体处理组、40 mg/L PHT+整合素β1抗体处理组、PBS处理组,每组细胞放入置有牙骨质片的96孔板处理4 h后,检测黏附于牙骨质片上的细胞量并做以比较。最后,利用qRT-PCR和Western blot检测40 mg/L PHT组与对照组细胞的整合素α5、β1亚基的mRNA与蛋白表达量。结果 40 mg/L PHT可促进rBMMSCs及rPDLSCs黏附于牙骨质片,加入整合素α5、β1抗体后,均明显抑制了40 mg/L PHT对rBMMSCs、rPDLSCs黏附于牙骨质的促进作用(P<0.01)。qRT-PCR、Western-blot结果显示PHT处理组的整合素α5、β1亚基表达量高于空白对照组(P<0.05)。结论 40 mg/L PHT能促进rBMMSCs、rPDLSCs黏附于牙骨质,该作用与整合素α5β1的表达上调密切相关。 相似文献
6.
7.
8.
9.
10.
BACKGROUND: Posterior spinal procedures through tubular exposures have been described. However, tubes restrain visibility and require co-axial instrument manipulation, increasing difficulty and potentially compromising surgical results. An independent-blade retractor system overcomes the obstacles of working through a tube and has been used to perform minimally-disruptive decompression and instrumented tranforaminal lumbar interbody fusion (TLIF). PURPOSE: To evaluate the advantages to patient recovery and surgical efficacy of this technique. METHODS/RESULTS: Retrospective review of technique employing a minimally-disruptive approach to decompression and transforaminal lumber interbody fusion (TLIF). CONCLUSIONS: Minimally-disruptive decompression and instrumented TLIF can be performed in a safe and effective manner using an independent-blade retractor system. Relative to traditional-open techniques, surgical goals can be accomplished, but with the benefits of minimally-disruptive surgery. 相似文献